Guangzhou Medprin Biomedical Technology Co., Ltd. Announcement on Amendments to the Report on Issuance of Shares and Payment of Cash to Purchase Assets and Raising of Supporting Funds and Connected Transactions (Draft)
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or significant omissions.
Guangzhou Medprin Biomedical Technology Co., Ltd. (hereinafter referred to as the "Listed Company" or the "Company") intends to acquire 100% equity of Guangzhou YiJie Medical Technology Co., Ltd. (hereinafter referred to as the "Target Company" or "YiJie Medical") held by Guangzhou ZeXin Medical Technology Co., Ltd., Guangzhou YiChuangXiang Investment Partnership (Limited Partnership), and 10 other counterparties by issuing shares and paying cash, and to raise supporting funds (hereinafter referred to as the "Transaction").